Sanctuary Advisors LLC Acquires 3,249 Shares of Waters Corporation $WAT

Sanctuary Advisors LLC lifted its holdings in shares of Waters Corporation (NYSE:WAT) by 295.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,347 shares of the medical instruments supplier’s stock after purchasing an additional 3,249 shares during the quarter. Sanctuary Advisors LLC’s holdings in Waters were worth $1,294,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of WAT. Brighton Jones LLC lifted its stake in Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after buying an additional 673 shares in the last quarter. Integrated Wealth Concepts LLC increased its position in shares of Waters by 2.9% during the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after acquiring an additional 30 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Waters by 3.6% during the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after acquiring an additional 6,976 shares in the last quarter. Empowered Funds LLC raised its holdings in shares of Waters by 16.6% during the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after acquiring an additional 160 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Waters during the second quarter worth $232,000. Institutional investors own 94.01% of the company’s stock.

Waters Stock Performance

Shares of WAT opened at $382.38 on Friday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15. The firm has a fifty day simple moving average of $364.32 and a 200 day simple moving average of $345.93. The stock has a market capitalization of $37.55 billion, a price-to-earnings ratio of 48.59, a PEG ratio of 2.24 and a beta of 1.20. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32.

Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.20 billion. During the same period in the previous year, the business earned $2.25 EPS. The company’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Research analysts forecast that Waters Corporation will post 14.51 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on WAT shares. Piper Sandler assumed coverage on shares of Waters in a research report on Thursday, June 11th. They issued a “neutral” rating and a $400.00 price objective on the stock. Guggenheim reissued a “buy” rating and issued a $440.00 price target on shares of Waters in a research note on Wednesday, July 8th. TD Cowen restated a “hold” rating on shares of Waters in a report on Wednesday, July 15th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a research report on Friday, July 17th. Finally, Wells Fargo & Company increased their price objective on Waters from $355.00 to $370.00 and gave the stock an “equal weight” rating in a report on Thursday, May 14th. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $401.60.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.